| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Hoffer A, Osmond H, Smyth... |
Schizophrenia; a new approach. II. Result of a year's research |
J Ment Sci |
1954 |
| Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
| Isbell H, Miner EJ, Logan... |
Relationships of psychotomimetic to anti-serotonin potencies of congen... |
Psychopharmacologia |
1959 |
| Delay J, Pichot P, Lempér... |
Les effets somatiques de la Psilocybine |
Presse méd. |
1959 |
| Woolley DW |
Serotonin in mental disorders |
Dis.Nerv.System |
1960 |
| Vojtechovsky M, Horácková... |
Pokus o blokováni experimentální psychózy po LSD-25 theadrylem. |
Csl. Psychiat. |
1960 |
| Pollard JC, Bakker C, Uhr... |
Controlled sensory input: a note on the technic of drug evaluation wit... |
Comprehensive Psychi... |
1960 |
| Savage C, Stolaroff MJ |
Clarifying the Confusion Regarding LSD-25 |
J. Nerv. Ment. Dis. |
1965 |
| Charalampous KD, Walker K... |
Metabolic fate of mescaline in man |
Psychopharmacologia |
1966 |
| Editorial |
Hazards of indiscriminate use of LSD getting across |
New York State Journ... |
1968 |
| Raichle ME, Posner JB, Pl... |
Cerebral blood flow during and after hyperventilation |
Arch Neurol |
1970 |
| Barr HL, Langs RJ, Holt R... |
LSD : Personality And Experience |
|
1972 |
| Klerman GL |
Psychotropic hedonism vs pharmacological Calvinism |
Hastings Cent Rep |
1972 |
| Klerman GL |
Drugs And The Dying Patient |
Psychopharmalogical ... |
1973 |
| Servadio E |
The use of LSD in the psychoanalytic treatment of a case of anxiety hy... |
Zeitschrift fur Psyc... |
1973 |
| Editorial |
FDA Lists Approved LSD Research Projects |
FDA Consumer |
1975 |
| Smithells RW |
Environmental Teratogens Of Man |
Brit.med.Bull. |
1976 |
| O'Callaghan JP, Miller DB |
Quantification of reactive gliosis as an approach to neurotoxicity ass... |
NIDA Res Monogr |
1993 |
| Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
| Anthony JC, Warner LA, Ke... |
Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled... |
Experimental and Cli... |
1994 |
| Shih JC, Chen K, Gallaher... |
Structure and Function of Serotonin 5-HT2 Receptors |
NIDA Research Monogr... |
1994 |
| Takeda N, Ikeda R, Ohba K... |
Bufotenine reconsidered as a diagnostic indicator of psychiatric disor... |
Neuroreport |
1995 |
| Gerada C, Ashworth M |
ABC of mental health. Addiction and dependence--I: Illicit drugs [publ... |
BMJ |
1997 |
| Towers S |
[Unknown] |
Accid Emerg Nurs |
1997 |
| Towers S |
Sorted |
Accid Emerg Nurs |
1997 |
| Gouzoulis-Mayfrank E, Hee... |
Effects of the hallucinogen psilocybin on habituation and prepulse inh... |
Behav Pharmacol |
1998 |
| Abrahart D |
A Critical Review of Theories and Research Concerning Lysergic Acid Di... |
Masters Thesis |
1998 |
| Grof S |
Human nature and the nature of reality: conceptual challenges from con... |
J Psychoactive Drugs |
1998 |
| Pedersen W, Skrondal A |
Ecstasy and new patterns of drug use: A normal population study. |
Addiction |
1999 |
| Spruit IP |
Ecstasy use and policy responses in the Netherlands |
Journal of Drug Issu... |
1999 |
| Collins AS, Sumner SC, Bo... |
A physiological model for tert-amyl methyl ether and tert-amyl alcohol... |
Toxicol Sci |
1999 |
| Gouzoulis-Mayfrank E, The... |
Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... |
Psychopharmacology (... |
1999 |
| Lerner AG, Gelkopf M, Oyf... |
LSD-induced hallucinogen persisting perception disorder treatment with... |
Int Clin Psychopharm... |
2000 |
| Jablensky A |
Epidemiology of schizophrenia: the global burden of disease and disabi... |
Eur Arch Psychiatry ... |
2000 |
| Hafner H |
Epidemiology of schizophrenia. A thriving discipline at the turn of th... |
Eur Arch Psychiatry ... |
2000 |
| Schreckenberger M, Gouzou... |
"Ecstasy"-induced changes of cerebral glucose metabolism and their cor... |
Eur J Nucl Med |
2000 |
| Weinbroum AA, Rudick V, P... |
The role of dextromethorphan in pain control |
Can J Anaesth |
2000 |
| Cami J, Farre M, et al |
Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... |
J Clin Psychopharmac... |
2000 |
| Liechti ME, Gamma A, Voll... |
Gender Differences in the Subjective Effects of MDMA |
Psychopharmacology |
2001 |
| Degenhardt L, Hall W |
The association between psychosis and problematical drug use among Aus... |
Psychol Med |
2001 |
| Pacifici R, Zuccaro P, Lo... |
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combin... |
J Pharmacol Exp Ther |
2001 |
| McCann UD, Ricaurte GA |
Caveat Emptor: Editors Beware |
Neuropsychopharmacol... |
2001 |
| Braff, DL, Geyer, MA and ... |
Human studies of prepulse inhibition of startle: normal subjects, pati... |
Psychopharmacology |
2001 |
| Lerner AG, Skladman I, Ko... |
LSD-induced Hallucinogen Persisting Perception Disorder treated with c... |
Isr J Psychiatry Rel... |
2001 |
| Gerra G, Zaimovic A, Ampo... |
Experimentally induced aggressive behavior in subjects with 3,4- methy... |
Journal of Substance... |
2001 |
| Johns LC, van Os J |
The continuity of psychotic experiences in the general population |
Clin Psychol Rev |
2001 |
| Klitzman RL, Greenberg JD... |
MDMA ('ecstasy') use, and its association with high risk behaviors, me... |
Drug Alcohol Depend |
2002 |
| Szabo Z, McCann UD, Wilso... |
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... |
J Nucl Med |
2002 |
| Gouzoulis-Mayfrank E, The... |
Effects of the hallucinogen psilocybin on covert orienting of visual a... |
Neuropsychobiology |
2002 |
| Wachtel SR, ElSohly MA, R... |
Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol ... |
Psychopharmacology (... |
2002 |
| Gouzoulis-Mayfrank E, The... |
Effects of the hallucinogen psilocybin on covert orienting of visual a... |
Neuropsychobiology |
2002 |
| Solomon PR, Adams F, Silv... |
Ginkgo for memory enhancement: a randomized controlled trial |
JAMA |
2002 |
| Eisen SA, Chantarujikapon... |
Does marijuana use have residual adverse effects on self-reported heal... |
Addiction |
2002 |
| Bellis MA, Hughes K, Lowe... |
Healthy nightclubs and recreational substance use. From a harm minimis... |
Addict Behav |
2002 |
| Riba J, Rodriguez-Fornel... |
Effects of ayahuasca on sensory and sensorimotor gating in humans as m... |
Psychopharmacology (... |
2002 |
| Jorm LR, Thackway SV, Chu... |
Watching the Games: public health surveillance for the Sydney 2000 Oly... |
J Epidemiol Communit... |
2003 |
| Halpern JH, Sholar MB, Gl... |
Diminished interleukin-6 response to proinflammatory challenge in men ... |
J Clin Endocrinol Me... |
2003 |
| Page WF |
Long-term health effects of exposure to sarin and other anticholineste... |
Mil Med |
2003 |
| Kim MK, Nightingale C, Ni... |
Influence of sex on the pharmacokinetic interaction of fleroxacin and ... |
Clin Pharmacokinet |
2003 |
| Reijneveld SA, Crone MR, ... |
The effect of a severe disaster on the mental health of adolescents: a... |
Lancet |
2003 |
| Verheyden SL, Henry JA, C... |
Acute, sub-acute and long-term subjective consequences of 'ecstasy' (M... |
Hum Psychopharmacol |
2003 |
| Lamers CT, Ramaekers JG, ... |
Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor ... |
J Psychopharmacol |
2003 |
| Verheyden SL, Maidment R,... |
Quitting ecstasy: an investigation of why people stop taking the drug ... |
J Psychopharmacol |
2003 |
| Wyatt JK, Cajochen C,Ritz... |
Low-Dose Repeated Caffeine Administration for Circadian-Phase–Dependen... |
SLEEP |
2004 |
| Roth BL, Lopez E, Beische... |
Screening the receptorome to discover the molecular targets for plant-... |
Pharmacol Ther |
2004 |
| Halpern JH |
Hallucinogens and dissociative agents naturally growing in the United ... |
Pharmacol Ther |
2004 |
| Pierre JM, Shnayder I, Wi... |
Intranasal quetiapine abuse |
Am J Psychiatry |
2004 |
| Kukanich B, Papich MG |
Plasma profile and pharmacokinetics of dextromethorphan after intraven... |
J Vet Pharmacol Ther |
2004 |
| Drewe M, Drewe J, Riecher... |
Cannabis and risk of psychosis |
Swiss Med Wkly |
2004 |
| Isaac M, Isaac M, Hollowa... |
Is cannabis an anti-antipsychotic? The experience in psychiatric inten... |
Hum Psychopharmacol |
2005 |
| Gebhardt DO |
Off-label administration of drugs to healthy military personnel. Dubio... |
J Med Ethics |
2005 |
| Peters RJ, Kelder SH, Mes... |
Beliefs and social norms about cigarettes or marijuana sticks laced wi... |
Subst Use Misuse |
2005 |
| Halpern JH, Sherwood AR, ... |
Psychological and Cognitive Effects of Long-Term Peyote Use Among Nati... |
Biological Psychiatr... |
2005 |
| Halpern JH, Sewell RA |
Hallucinogenic botanicals of America: a growing need for focused drug ... |
Life Sci |
2005 |
| Halpern JH, Sewell RA |
Hallucinogenic Botanicals of America: A growing need for focused drug ... |
Life Sci |
2005 |
| Wittmann M, Carter O, Has... |
Effects of psilocybin on time perception and temporal control of behav... |
J Psychopharmacol |
2006 |
| Padosch SA, Lachenmeier D... |
Absinthism: a fictitious 19th century syndrome with present impact |
Subst Abuse Treat Pr... |
2006 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| Kleber HD |
Commentary on: Psilocybin can occasion mystical-type experiences havin... |
Psychopharmacology (... |
2006 |
| Rasmussen N |
Making the first anti-depressant: amphetamine in American medicine, 19... |
J Hist Med Allied Sc... |
2006 |
| Tanner-Smith EE |
Pharmacological content of tablets sold as 'ecstasy': results from an ... |
Drug Alcohol Depend |
2006 |
| Furey ML, Drevets WC |
Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... |
Arch Gen Psychiatry |
2006 |
| Robertson JR, Raab GM, Br... |
Addressing the efficacy of dihydrocodeine versus methadone as an alter... |
Addiction |
2006 |
| Moore TH, Zammit S, Lingf... |
Cannabis use and risk of psychotic or affective mental health outcomes... |
Lancet |
2007 |
| Vainiotalo S, Riihimäki V... |
Toxicokinetics of methyl tert-butyl ether (MTBE) and tert-amyl methyl ... |
J Occup Environ Hyg |
2007 |
| Deakin JF, Lees J, McKie ... |
Glutamate and the neural basis of the subjective effects of ketamine: ... |
Arch Gen Psychiatry |
2008 |
| Cifelli CJ, Green JB, Wan... |
Kinetic analysis shows that vitamin A disposal rate in humans is posit... |
J Nutr |
2008 |
| Burri A, Heinrichs M, Sch... |
The acute effects of intranasal oxytocin administration on endocrine a... |
Psychoneuroendocrino... |
2008 |
| Muetzelfeldt L, Kamboj SK... |
Journey through the K-hole: phenomenological aspects of ketamine use |
Drug Alcohol Depend |
2008 |
| McDonough PC, Holler JM, ... |
The detection and quantitative analysis of the psychoactive component ... |
J Anal Toxicol |
2008 |
| Bossong MG, van Berckel B... |
Delta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Stri... |
Neuropsychopharmacol... |
2008 |
| Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
| Khan MA, Akella S |
Cannabis-induced bipolar disorder with psychotic features: a case repo... |
Psychiatry (Edgmont) |
2009 |
| Comer SD, Sullivan MA, Vo... |
Abuse liability of oxycodone as a function of pain and drug use histor... |
Drug Alcohol Depend |
2010 |
| Karila L, Reynaud M |
GHB and synthetic cathinones: clinical effects and potential consequen... |
Drug Test Anal |
2010 |
| Kelly BC |
Legally tripping: a qualitative profile of Salvia divinorum use among ... |
J Psychoactive Drugs |
2011 |
| Wu LT, Woody GE, Yang C, ... |
Recent national trends in Salvia divinorum use and substance-use disor... |
Subst Abuse Rehab |
2011 |
| Parrott AC, Gibbs A, Scho... |
MDMA and methamphetamine: some paradoxical negative and positive mood ... |
Psychopharmacology (... |
2011 |
| Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
| Bar-Or D, Salottolo KM, O... |
A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Eva... |
Eur Urol |
2011 |
